Nektar Therapeutics

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Nektar Therapeutics, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Nektar Therapeutics please access flcube.com

Company Deals

Autobio Diagnostics and Haier Biomedical Sign Strategic Cooperation Agreement – AI‑Driven Alliance to Build Holistic Smart Laboratory Solutions Across IVD, Automation, and Medical Informatization

Autobio Diagnostics Co., Ltd. (SHA: 603658) and Haier Biomedical (SHA: 688139) signed a strategic cooperation agreement, joining forces across in vitro diagnostics (IVD), laboratory automation, and medical informatization to drive…

November 13, 2026

TenNor Therapeutics Reports Multiple R&D Milestones for Rifasutenizol and Rifaquinone – NDA Supplementary Package Complete as First‑in‑Class Triple‑Target Agent Advances Against Device‑Associated Infections

November 13, 2026

CureGene Pharmaceutical and Walvax Biotechnology Sign Strategic MOU – Full‑Chain Alliance to Accelerate Innovative Nucleic Acid Drugs from AI‑Enabled mRNA R&D to Large‑Scale Manufacturing

November 13, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.

Explore Now

Company Legal / IP